Purchase Order HHSN275201400370P
Award Date
9/11/14
Potential Completion Date
10/31/14
Potential Value
$5.7K
Federal Agency
National Institute of Child Health and Human Development
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Herndon, VA 20191, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services' National Institutes of Health National Institute of Child Health and Human Development awarded a $19,210 purchase order to Horizon Genomics GMBH for "OTHER FUNCTIONS - HAP 1 KNOCKOUT CELLS & HAP1 CELLS." Horizon Genomics GMBH, a subsidiary of Haplogen GMBH, will deliver the requested HAP1 knockout and HAP1 cells under a firm fixed price contract with performance taking place in Bethesda, Maryland over a three-month period concluding in...
This firm fixed-price purchase order for $18,204.88 was awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse to Genscript USA Inc. to obtain cell lines utilizing CRISPR gene editing technology. Specifically, the contract calls for Genscript to generate knockout HEK293 and HepG2 cell lines of the MMAB and MUT genes to support studies for hereditary disorders of vitamin B12 and methylmalonic acid metabolism. No set-aside designation...
This is a $88,310 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Synthego Corporation, a small disadvantaged business manufacturer of gene editing products. The contract is for CRISPR gene editing services to develop five different induced pluripotent stem (iPS) cell lines expressing fluorescent proteins or HiBiT tags at specific target genes. This is a non-competitive award under...
This firm fixed-price purchase order was awarded by the National Institute of Child Health and Human Development (NICHD), part of the Department of Health and Human Services, to Applied Stemcell, Inc. for the generation of a conditional knockout mouse model using CRISPR/Cas9 gene editing technology. The award amount is $26,065.00, and the period of performance runs through July 19, 2021. The contract does not have a set-aside designation. Applied Stemcell is a minority-owned, woman-owned small...
This is a $25,150.00 firm fixed price purchase order contract awarded by the National Institute of Child Health and Human Development (NICHD), part of the Department of Health and Human Services, to Synthego Corporation, a small disadvantaged business manufacturer of gene editing products. The contract is for CRISPR genome engineering and related services to support biomedical research efforts across multiple NIH institutes. Synthego specializes in custom cell line development, gene...
The Department of Health and Human Services' National Institutes of Health's National Institute of Child Health and Human Development awarded a $14,141.84 purchase order to Genscript USA Inc. for "OTHER FUNCTIONS - CUSTOMIZED GENE SYNTHESES" to be performed in Bethesda, Maryland between September 8-16, 2016. As a firm fixed price contract for customized gene synthesis services, Genscript will deliver specified genetic material to the NIH organization to support its biomedical...
This is a $13,760 firm fixed price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Applied Stemcell, Inc. for the generation of point mutation induced pluripotent stem (iPS) or embryonic stem (ES) cell lines using CRISPR/Cas9 gene editing technology. The work is to be performed in Bethesda, MD and has a completion date of March 31, 2022. Applied Stemcell, Inc. is a minority-owned, woman-owned small business that provides...
The Department of Health and Human Services' National Institutes of Health's National Institute of Child Health and Human Development awarded a $10,000 purchase order to Genscript USA Inc. to deliver a 2000 base pair gene synthesis in a PUC57 vector with 4 micrograms of the synthesized gene. The place of performance for this firm fixed price contract is in Bethesda, Maryland. This purchase supports the NIH's mission to conduct and fund medical research that could improve public health, likely...
This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), which is part of the Department of Health and Human Services (HHS). The contract was awarded to Genscript USA Inc., a small business biotechnology company based in Piscataway, New Jersey, for $11,434.95. The contract has an ultimate completion date of July 30, 2025. Genscript specializes in gene synthesis, gene editing, custom protein and antibody production, and other...
This firm fixed-price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to Synthego Corporation, a small disadvantaged business, for the development of induced pluripotent stem (iPS) report cell lines expressing HiBiT at specified target genes. The $235,150.00 contract has a 20-24 week period of performance and does not have a set-aside designation. The work will be performed at Synthego's...